Lupin gets CDSCO nod for 2nd generation antihistanine medicine

The Central Drugs Standard Control Organisation (CDSCO) has given its approval to Mumbai-based multinational pharmaceutical company Lupin Limited for Bepotastine

Read more

Lupin launches intra-articular knee injection Hyalgan in India

Close on the heels of announcing its foray in the orthopaedic segment, Lupin Limited, has announced the availability of Hyalgan, a therapy against degenerative joint disease-osteoarthritis, in India.

Read more

Apollo, Lupin unveil country’s first disease management plan

Apollo Hospitals Group has joined hands with Lupin Limited, a leading pharma major, to create the first Disease Management Programme (DMP) for Bronchial Asthma and COPD (Chronic Bronchitis) in the name of Apollo’s ‘BreatheEasy Clinic’.

Read more

Blogs new window to the world for Pharma industry

Pharma blogs are playing an important role in shaping the future of the pharmaceutical industry in India. Many Indian online financial portal and investment firms as well as research organisations have provided a blogging platform for the pharma industry to keep itself updated with the development in the pharma world through open and uncensored discussion.

Read more

NEWS REVIEW – BUSINESS

[This article was published in the January 2008 issue of the eHEALTH Magazine (http://www.ehealthonline.org)]

News

Read more